• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS UNKNOWN PROGRIP MESH PRODUCT; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS UNKNOWN PROGRIP MESH PRODUCT; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number LPG1510
Device Problems Migration or Expulsion of Device (1395); Material Deformation (2976); Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Adhesion(s) (1695); Emotional Changes (1831); Foreign Body Reaction (1868); Inflammation (1932); Nerve Damage (1979); Neuropathy (1983); Pain (1994); Scar Tissue (2060); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a right inguinal hernia.It was reported that after implant, the patient experienced defective mesh, mental pain, scarring, permanent impairment, loss of enjoyment of life, pain, inflammation, adhesions, and mesh migration.Post-operative patient treatment included intervention surgery.
 
Manufacturer Narrative
Additional information: a2, a3, b5, b7, d4 (model#, catalogue, implant date, explant date), d8, g1 (manufacturer name, first name, last name, street 1, city, region, postal code, email, phone), g4 (510k), h6 (patient codes).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a right inguinal hernia.It was reported that after implant, the patient experienced defective mesh, mental pain, scarring, permanent impairment, loss of enjoyment of life, pain, inflammation, adhesions, suffering, nerve damage, foreign body giant cell response, and mesh migration.Post-operative patient treatment included intervention surgery, iloinguinal neuropathy, resection of inguinal nerve, and mesh removal.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a right inguinal hernia.It was reported that after implant, the patient experienced right ilioinguinal neuropathy, nerve entrapment, scrotal pain, mesh buckling, loss of tissue planes, nonvascular tubular structure in inguinal soft tissues, bilateral hydroceles, defective mesh, mental pain, scarring, permanent impairment, loss of enjoyment of life, pain, inflammation, adhesions, suffering, nerve damage, foreign body giant cell response, and mesh migration.Post-operative patient treatment included application of hemp oil, surgery for right ileal inguinal neuropathic pain, exploration of rlq division of right ilioinguinal nerve, ultrasound guided injection to right ilioinguinal nerve, pain medication, laparoscopy, nerve resection, spermatic cord block, lumbar spine injection, procedure for right inguinal neuropathy, use of antibiotics, opioid therapy for right inguinal pain, ct scan, ultrasound, intervention surgery, iloinguinal neuropathy, resection of inguinal nerve, and mesh removal.
 
Manufacturer Narrative
Additional info: h6 (patient codes, device code, imf codes, ime e2402: "bilateral hydroceles, nonvascular tubular structure, loss of tissue planes, nerve entrapment").Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN PROGRIP MESH PRODUCT
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
justin ellis
5920 longbow drive
8200 coral sea st ne
mounds view,mn, CO 55112
7635265677
MDR Report Key14283207
MDR Text Key290794054
Report Number9615742-2022-00423
Device Sequence Number1
Product Code FTL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K120897
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 02/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberLPG1510
Device Catalogue NumberLPG1510
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/13/2022
Initial Date FDA Received05/04/2022
Supplement Dates Manufacturer Received02/01/2023
02/15/2023
Supplement Dates FDA Received02/08/2023
02/27/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
Patient SexMale
Patient Weight82 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-